ESMO 2024: Focus on Lung Cancer Coverage

ESMO 2024: Focus on Lung Cancer

Shirish M. Gadgeel, MDESMO 2024: Focus on Lung Cancer | October 1, 2024

Shirish M. Gadgeel, MD, discusses the phase 1/2 ARROS-1 and ALKOVE-1 studies presented at the ESMO 2024 Congress.

Cecilia BrownESMO 2024: Focus on Lung Cancer | September 19, 2024

Researchers presented an updated safety and efficacy analysis at the ESMO 2024 Congress.

Molly Li, MBBSESMO 2024: Focus on Lung Cancer | September 19, 2024

The trial is evaluating perioperative pembrolizumab plus sacituzumab govitecan for certain patients with NSCLC.

Molly Li, MBBSESMO 2024: Focus on Lung Cancer | September 17, 2024

Dr. Li discusses important thoracic oncology data presented at the ESMO 2024 Congress, which was held in Barcelona, Spain

Benjamin Besse, MD, PhDESMO 2024: Focus on Lung Cancer | September 16, 2024

Benjamin Besse, MD, PhD, shares insights from the research he presented as a late-breaking abstract at ESMO 2024.

Martin Reck, MD, PhDESMO 2024: Focus on Lung Cancer | September 12, 2024

Martin Reck, MD, PhD, shares his insights on key data in lung cancer to be presented at the ESMO Congress 2024.